BackPT Kalbe Farma Tbk Overview

PT Kalbe Farma Tbk Net Income

Latest net income for PTKFF: $3T, above the Healthcare sector average of $16B.

Get informed when a big investor buys or sells

+ Follow

Quarterly Net Income

$896.91B
0.14% YoY

As of Jun 2026

Annual Net Income (TTM)

$2961.89B
4.39% YoY

Trailing 12 months ending Jun 2026

Average Net Income (Comparison Companies)

Loading

Net Income History

Loading

Net Income Comparison

Loading

Annual Net Income Growth Rate (%)

Loading...

Annual Net Income Growth (Absolute)

Loading...

PT Kalbe Farma Tbk (PTKFF) FAQ

PT Kalbe Farma Tbk (PTKFF) currently reports a net income of $3T as of June 2026. That compares with $2.8T in the prior-year period — up 4.4% year over year. That is above the Healthcare sector average of $16B. Use the charts on this page to explore PT Kalbe Farma Tbk's net income history and peer comparisons.

PT Kalbe Farma Tbk's net income increased from $2.8T to $3T — a 4.4% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

PT Kalbe Farma Tbk's net income of $3T is higher than the Healthcare sector average of $16B. That is roughly 17938.1% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

PT Kalbe Farma Tbk reported $3T in net income as of June 2026. That compares with $2.8T in the prior-year period — up 4.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net income of $3T, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $16B. From there, open related valuation or income-statement pages for PT Kalbe Farma Tbk, and consider following PTKFF for alerts when major investors trade the stock.